FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

13506111000001105: Circadin 2mg modified-release tablets (Lundbeck Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
48500301000001112 Circadin 2mg modified-release tablets (Lundbeck Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66552001000001119 Circadin 2mg modified-release tablets (Flynn Pharma Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Circadin 2mg modified-release tablets (Lundbeck Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Is a Melatonin 2mg modified-release tablets true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Has active ingredient Melatonin true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Is a Circadin true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Has specific active ingredient Melatonin true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Circadin 2mg modified-release tablets (Lundbeck Ltd) 21 tablet Is pack of False Circadin 2mg modified-release tablets (Lundbeck Ltd) Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Lundbeck Ltd) 21 tablet Has AMP True Circadin 2mg modified-release tablets (Lundbeck Ltd) Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Flynn Pharma Ltd) 30 tablet 2 x 15 tablets Has AMP True Circadin 2mg modified-release tablets (Lundbeck Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start